| Catch a partial lunar eclipse during September’s supermoon |
AP Online |
09/14 |
09:00 |
| EagleView Captures High-Resolution Aerial Imagery and Data of Hurricane Francine at Unmatched 1-Inch GSD, Supporting Immediate Recovery Efforts |
Globe Newswire |
09/14 |
09:00 |
| Medigene Presents Progress on KRAS Library and UniTope & TraCR Technology at ESMO 2024 |
Globe Newswire |
09/14 |
07:30 |
| KFSHRC Revolutionizes Patient Care with Pioneering Experience Ambassadors Program |
Globe Newswire |
09/14 |
07:11 |
| US hits Russian state media with sanctions for raising money for Moscow's troops in Ukraine |
AP Online |
09/14 |
04:32 |
| Acrivon Therapeutics Reports Positive Endometrial Cancer Data from Ongoing ACR-368 Registrational Intent Phase 2 Study at ESMO, Advancement of ACR-2316 into Clinic Ahead of Timelines, and Progress on its AP3 Interactome for Proprietary Data Analysis |
Globe Newswire |
09/14 |
03:10 |
| Transgene and BioInvent’s Oncolytic Virus BT-001 Shows Promising Antitumor Activity in Ongoing Phase I/IIa Trial in Solid Tumors that Failed Previous Treatments |
Globe Newswire |
09/14 |
03:05 |
| NuCana Presents Encouraging Data on NUC-7738 in Combination with Pembrolizumab in PD-1 Inhibitor Refractory and Resistant Melanoma Patients at the ESMO Congress 2024 |
Globe Newswire |
09/14 |
03:01 |
| Immunocore presents Phase 1 data of brenetafusp, an ImmTAC bispecific targeting PRAME, in patients with ovarian cancer |
Globe Newswire |
09/14 |
03:00 |
| Avacta Reports Updated Phase 1 Clinical Data of AVA6000 at the European Society for Medical Oncology (ESMO) Congress Demonstrating Multiple Ongoing, Durable Responses in Solid Tumors |
Globe Newswire |
09/14 |
03:00 |
| Sutro Biopharma Announces Updated Data from Phase 1b Study of Luvelta in Combination with Bevacizumab at ESMO 2024 |
Globe Newswire |
09/14 |
03:00 |
| iTeos Announces Clinically Meaningful Objective Response Rate Observed at Every Dose in Follow-up Interim Analysis of GALAXIES Lung-201 Study of Belrestotug + Dostarlimab in First-Line, PD-L1 High Non-Small Cell Lung Cancer Patients |
Globe Newswire |
09/14 |
02:30 |
| Going once, going twice: Google's millisecond ad auctions are the focus of monopoly claim |
AP Online |
09/14 |
00:17 |
| The Biden administration is taking steps to eliminate protections for gray wolves |
AP Online |
09/13 |
21:12 |
| Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Indivior, CrowdStrike, DXC, and Five Below and Encourages Investors to Contact the Firm |
Globe Newswire |
09/13 |
21:00 |
| Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CAE, MacroGenics, Vicor, and American Airlines and Encourages Investors to Contact the Firm |
Globe Newswire |
09/13 |
21:00 |
| KBW Announces Index Rebalancing for Third-Quarter 2024 |
Globe Newswire |
09/13 |
20:30 |
| Greystone Logistics Reports Strong Year-End Earnings |
Globe Newswire |
09/13 |
18:40 |
| COIN INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Coinbase Global, Inc. Investors with Substantial Losses Have Opportunity to Lead the Coinbase Class Action Lawsuit |
Globe Newswire |
09/13 |
18:38 |
| A tech company hired a top NYC official's brother. A private meeting and $1.4M in contracts followed |
AP Online |
09/13 |
17:47 |
| LemVega Capital, the Leading Investment Management Firm, on Track to Become a Global Financial Powerhouse |
Globe Newswire |
09/13 |
17:41 |
| Stock market today: Wall Street’s best week of 2024 closes with indexes near their records |
AP Online |
09/13 |
17:26 |
| Stuck-in-space astronauts reflect on being left behind and adjusting to life in orbit |
AP Online |
09/13 |
17:20 |
| Pope slams both Harris and Trump as 'against life' and urges Catholics to vote for 'lesser evil' |
AP Online |
09/13 |
17:07 |
| Upwork Confirms Receipt and Comments on Shareholder Letter |
Globe Newswire |
09/13 |
17:03 |
